We are proud to announce the International Viral Hepatitis Elimination Meeting (IVHEM) scheduled for 4-5 December 2020 in Amsterdam, the Netherlands. IVHEM is a global forum for the exchange of practical experiences for translating diagnostic and therapy advances of viral hepatitis into broad applications that accelerate progress toward elimination of viral hepatitis as a public health threat by 2030.
- Want to stay informed about IVHEM 2020? Click here to subscribe to the IVHEM newsletter
- IVHEM is endorsed by (inter)national organizations. Their support and collaboration are key to the success of this conference. Get in touch with us if you want your organization to be part of IVHEM 2020.
- Curious about the meeting proceedings of the previous edition? Find presentations and webcasts here.
Addressing key issues to eliminate viral hepatitis
Hepatitis B and C affect more than 320 million people globally and can lead to liver disease and mortality from liver failure and hepatocellular carcinoma. More than 248 million people (3.8% of the world’s population) are chronically infected with HBV, and over 700,000 attributable deaths annually. An estimated 80 million people (globally, 1.1%) are chronically infected with hepatitis C virus (HCV), resulting in nearly 500,000 deaths annually.
Key issues to be addressed are how to translate research outcomes into public health policy and practice to meet the 2030 elimination targets. During this two day meeting, experts in viral hepatitis from around the globe will examine current evidence on how to implement programs that improve the prevention of viral hepatitis, and increase the number of people accessing testing and treatment.
The program includes practical examples of innovative intervention studies, country elimination programs and novel funding mechanisms for testing and treatment.
We invite you to contribute to elimination of viral hepatitis and look forward to welcoming you to this unique meeting in Amsterdam!
The Program Committee
- To provide a forum for knowledge exchange and discussion of practical experiences related to the clinical management of viral hepatitis
- To provide a toolbox for practical application of research & development for evidence based policy making
- To facilitate cross-disciplinary discussion on barriers and challenges preventing the elimination of viral hepatitis